111 Inc. (YI)
NASDAQ: YI
· Real-Time Price · USD
7.65
-0.34 (-4.26%)
At close: May 12, 2025, 3:58 PM
7.98
4.31%
After-hours: May 12, 2025, 04:05 PM EDT
111 Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Drugs Revenue | 13.4B | 13.88B | 12.57B | 11.68B | 7.4B | 3.6B | 1.49B |
| Drugs Revenue Growth | -3.49% | +10.42% | +7.63% | +57.89% | +105.77% | +141.32% | n/a |
| MP Service Revenue | 65.54M | 70.27M | 68.48M | 52.31M | 149.05M | 50.18M | 26.56M |
| MP Service Revenue Growth | -6.74% | +2.62% | +30.91% | -64.91% | +197.04% | +88.90% | n/a |
| Medical Supplies And Devices Revenue | 144.28M | 157.5M | 164.92M | 12.33B | 559.24M | 245.64M | 190.43M |
| Medical Supplies And Devices Revenue Growth | -8.39% | -4.49% | -98.66% | +2105.09% | +127.66% | +29.00% | n/a |
| Nutritional Supplements Revenue | 550.46M | 631.12M | 554.79M | 94.2M | 46.53M | 20.35M | 16.03M |
| Nutritional Supplements Revenue Growth | -12.78% | +13.76% | +488.97% | +102.45% | +128.68% | +26.95% | n/a |
| Other Products Revenue | 201.83M | 170.23M | 111.1M | n/a | 8.16B | 3.93B | 1.77B |
| Other Products Revenue Growth | +18.56% | +53.23% | n/a | n/a | +107.56% | +121.99% | n/a |
| Product Revenue | 14.29B | 14.84B | 13.4B | n/a | 46.48M | 22.36M | 15.74M |
| Product Revenue Growth | -3.69% | +10.73% | n/a | n/a | +107.94% | +42.00% | n/a |
| Service Revenue | 106.51M | 106.22M | 113.26M | n/a | n/a | n/a | n/a |
| Service Revenue Growth | +0.27% | -6.22% | n/a | n/a | n/a | n/a | n/a |
| Service, Other Revenue | 40.97M | 35.95M | 44.78M | n/a | n/a | n/a | n/a |
| Service, Other Revenue Growth | +13.98% | -19.73% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 96.33M | 91.32M | 97.72M | 99.43M | 271.47M | 141.36M | 129.2M | 258.52M | 363.11M | 283.63M | 261.29M | 296.4M | 175.69M | 341.52M | 321.76M | 290.52M | 150.18M | 212.87M | 181.51M | 202.05M | 138.43M | 165.42M | 143.27M | 139.28M | 112.29M | 144.64M | 120.84M | 83.72M | 89.84M | 89.64M | 59.97M | 56.43M |
| Selling, General, and Administrative Revenue Growth | +5.49% | -6.54% | -1.73% | -63.37% | +92.04% | +9.42% | -50.03% | -28.80% | +28.02% | +8.55% | -11.85% | +68.71% | -48.56% | +6.14% | +10.75% | +93.44% | -29.45% | +17.28% | -10.16% | +45.95% | -16.32% | +15.46% | +2.86% | +24.04% | -22.37% | +19.70% | +44.33% | -6.82% | +0.23% | +49.47% | +6.27% | n/a |
| Research and Development Revenue | n/a | n/a | 18.37M | 18.31M | 49.1M | 25.39M | 24.54M | 25.32M | 37.23M | 29.54M | 33.71M | 39.02M | 30.88M | 56.06M | 52.64M | 49.7M | 30.69M | 21.95M | 18.4M | 21.04M | 19.88M | 14.7M | 12.3M | 15.03M | 20.44M | 20.16M | 17.47M | 13.18M | 11.7M | 11.93M | 11.79M | 12.72M |
| Research and Development Revenue Growth | n/a | -100.00% | +0.32% | -62.71% | +93.41% | +3.44% | -3.06% | -32.00% | +26.04% | -12.37% | -13.61% | +26.35% | -44.91% | +6.49% | +5.93% | +61.96% | +39.78% | +19.28% | -12.52% | +5.83% | +35.27% | +19.48% | -18.17% | -26.48% | +1.43% | +15.40% | +32.50% | +12.71% | -1.95% | +1.17% | -7.28% | n/a |
| Sales and Marketing Revenue | 76.17M | 76.95M | 80.41M | 80.36M | 173.51M | 95.52M | 90.12M | 89.24M | 134.05M | 107.8M | 101.17M | 114.85M | 125.33M | 131.84M | 133.54M | 122.43M | 118.41M | 104.25M | 81.2M | 95.75M | 102.93M | 87.13M | 75.04M | 75.46M | 78.22M | 77.35M | 62.48M | 42M | 46.7M | 50.21M | 48.07M | 45.09M |
| Sales and Marketing Revenue Growth | -1.01% | -4.30% | +0.06% | -53.68% | +81.64% | +6.00% | +0.98% | -33.43% | +24.35% | +6.55% | -11.91% | -8.36% | -4.93% | -1.28% | +9.08% | +3.40% | +13.58% | +28.39% | -15.20% | -6.98% | +18.13% | +16.12% | -0.56% | -3.52% | +1.12% | +23.80% | +48.77% | -10.07% | -7.00% | +4.46% | +6.60% | n/a |